Elevance Health Inc (ELV) stock saw a decline, ending the day at $400.96 which represents a decrease of $-0.40 or -0.10% from the prior close of $401.36. The stock opened at $397.16 and touched a low ...

The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, ...

After a dip in the wake of the release of UnitedHealth Group's Q4 2024 earnings figures, shares in the company and other ...

Health-care companies rose sharply amid strong earnings.

Wall Street was mixed in premarket trading on Thursday as major U.S. airlines stumbled and health insurance companies soared ...

Elevance Health posted $418 million in profit for the fourth quarter of 2024, a figure that surpassed Wall Street's ...

U.S. stocks are drifting near a record as Wall Street’s recent rally loses some momentum. The S&P 500 slipped 0.1% in early ...

(Reuters) -Elevance Health on Thursday posted quarterly profit slightly above Wall Street expectations, helped by lower-than-expected spending on medical care for its members. The results lifted ...

Elevance Health Inc. (ELV), while reporting weak fourth-quarter earnings below market estimates, on Thursday issued fiscal 2025 ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

Premium revenue is expected to rise in the low double-digit percentage range, while product revenue rises in the low single-digit range and service fees come in flat year-over-year. Overall, operating ...

Societe Generale 's French retail recovery is key, Jefferies said. Industry data suggests banks should start their engines of loan production after almost two years of subdued loan issuance and higher ...